This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
As part of its corporate restructuring, Bayer AG has licensed Schering-Plough exclusive US and Puerto Rican marketing and distribution rights to all the primary care pharma products of its US subsidiary Bayer HealthCare. In turn, S-P has licensed Bayer Japanese co-promotion rights to its cholesterol absorption inhibitor Zetia (ezetimibe), which is currently under review for CV disorders (if approved, Bayer Yakuhin will market it).
Product or Technology Swap
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?